Free tool
Stocks listed on Nasdaq CM
We cover 33 companies listed on Nasdaq CM. The median market value in the group is $3.07B. Across the group, the median move over the past trading day is +1.63%. 74% of the 31 with a 200-day average trade above it. Price change over the past year runs from −12.1% to +278.5% across the middle 80 percent of the group, with a median of +77.5%.
Other lists in this group
Table
33 of 1,344 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| TGTX | TG Therapeutics, Inc. Common Stock | $8.48B | Mid cap | +96.32% | Nov 2, 2026 |
| RIOT | Riot Platforms, Inc. | $7.99B | Mid cap | +60.39% | Oct 29, 2026 |
| BLTE | Belite Bio, Inc | $6.51B | Mid cap | +154.13% | Nov 9, 2026 |
| LQDA | Liquidia Corporation | $6.31B | Mid cap | +168.53% | Nov 3, 2026 |
| ALM | Almonty Industries Inc. | $5.19B | Mid cap | +341.26% | Nov 6, 2026 |
| BULL | Webull Corporation | $4.74B | Mid cap | −40.24% | Nov 12, 2026 |
| ONDS | Ondas Inc. | $4.70B | Mid cap | +69.90% | Nov 12, 2026 |
| MARA | MARA Holdings, Inc. | $4.57B | Mid cap | −23.18% | Nov 4, 2026 |
| CELC | Celcuity Inc. | $4.44B | Mid cap | +87.35% | Nov 11, 2026 |
| VKTX | Viking Therapeutics, Inc. | $3.99B | Mid cap | +32.19% | Oct 28, 2026 |
| SEZL | Sezzle Inc. | $3.97B | Mid cap | +34.43% | Nov 4, 2026 |
| PLSE | Pulse Biosciences, Inc. | $3.50B | Mid cap | +197.94% | Nov 5, 2026 |
| PPTA | Perpetua Resources Corp. | $3.38B | Mid cap | +49.53% | Nov 12, 2026 |
| IMNM | Immunome, Inc. | $3.34B | Mid cap | +196.22% | Nov 5, 2026 |
| PLUG | Plug Power Inc. | $3.17B | Mid cap | +29.94% | Nov 9, 2026 |
| AEHR | Aehr Test Systems, Inc. | $3.12B | Mid cap | +288.74% | Oct 8, 2026 |
| BTDR | Bitdeer Technologies Group | $3.07B | Mid cap | −13.95% | Nov 9, 2026 |
| SLS | SELLAS Life Sciences Group, Inc. | $2.89B | Mid cap | +637.70% | Nov 11, 2026 |
| RGC | Regencell Bioscience Holdings Limited | $2.74B | Mid cap | −54.89% | Oct 28, 2026 |
| VRDN | Viridian Therapeutics, Inc. | $2.74B | Mid cap | +30.21% | Nov 5, 2026 |
| AXGN | AxoGen, Inc. Common Stock | $2.68B | Mid cap | +237.59% | Oct 28, 2026 |
| OSW | OneSpaWorld Holdings Limited | $2.67B | Mid cap | +17.85% | Oct 28, 2026 |
| NN | NextNav Inc. | $2.65B | Mid cap | −4.54% | Nov 5, 2026 |
| NKTR | Nektar Therapeutics | $2.52B | Mid cap | +176.20% | Nov 12, 2026 |
| MBIN | Merchants Bancorp | $2.48B | Mid cap | +66.90% | Oct 27, 2026 |
| HYMC | Hycroft Mining Holding Corporation | $2.43B | Mid cap | +545.54% | Oct 27, 2026 |
| UFPT | UFP Technologies, Inc. | $2.36B | Mid cap | +37.69% | Nov 2, 2026 |
| NEO | NeoGenomics, Inc. | $2.19B | Mid cap | +160.31% | Oct 27, 2026 |
| SHAZ | SharonAI Holdings Inc. | $2.18B | Mid cap | +92.33% | Nov 5, 2026 |
| ESTA | Establishment Labs Holdings Inc. | $2.15B | Mid cap | +77.45% | Nov 4, 2026 |
| PURR | Hyperliquid Strategies Inc. | $2.13B | Mid cap | +204.36% | Aug 27, 2026 |
| LIND | Lindblad Expeditions Holdings, Inc. | $2.08B | Mid cap | +112.45% | Nov 3, 2026 |
| PIII | P3 Health Partners Inc. | $2.06B | Mid cap | +35.72% | Nov 12, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.